Skip to main content

Site notifications

LETYBO (CROMA Australia Pty Ltd)

Product name
LETYBO
Date registered
Evaluation commenced
Decision date
Approval time
222 (255 working days)
Active ingredients
letibotulinumtoxinA
Registration type
NCE/NBE
Indication

LETYBO is indicated for the temporary improvement in the appearance of moderate to severe glabellar frown lines in adults.

Help us improve the Therapeutic Goods Administration site